TY - JOUR
T1 - Acute and repeated impact of sweeteners and sweetness enhancers in solid and semi-solid foods on appetite
T2 - protocol for a multicentre, cross-over, RCT in people with overweight/obesity - the SWEET Project
AU - Gibbons, Catherine
AU - O'Hara, Beverley
AU - O'Connor, Dominic
AU - Hardman, Charlotte
AU - Wilton, Moon
AU - Harrold, Joanne A.
AU - Almiron-Roig, Eva
AU - Navas-Carretero, Santiago
AU - Hodgkins, Charo E.
AU - Nazare, Julie Anne
AU - Alligier, Maud
AU - Martínez, Jose Alfredo
AU - Scott, Corey
AU - Kjølbæk, Louise
AU - Normand, Mie
AU - Rannou, Cécile
AU - Blaak, Ellen E.
AU - Feskens, Edith
AU - Moshoyiannis, Hariklia
AU - Raben, Anne
AU - Halford, Jason C.G.
AU - Beaulieu, Kristine
AU - Finlayson, Graham
PY - 2022/12
Y1 - 2022/12
N2 - INTRODUCTION: Intake of free sugars in European countries is high and attempts to reduce sugar intake have been mostly ineffective. Non-nutritive sweeteners and sweetness enhancers (S&SEs) can maintain sweet taste in the absence of energy, but little is known about the impact of acute and repeated consumption of S&SE in foods on appetite. This study aims to evaluate the effect of acute and repeated consumption of two individual S&SEs and two S&SE blends in semisolid and solid foods on appetite and related behavioural, metabolic and health outcomes. METHODS AND ANALYSIS: A work package of the SWEET Project; this study consists of five double-blind randomised cross-over trials which will be carried out at five sites across four European countries, aiming to have n=213. Five food matrices will be tested across three formulations (sucrose-sweetened control vs two reformulated products with S&SE blends and no added sugar). Participants (body mass index 25-35 kg/m2; aged 18-60 years) will consume each formulation for 14 days. The primary endpoint is composite appetite score (hunger, inverse of fullness, desire to eat and prospective food consumption) over a 3-hour postprandial incremental area under the curve during clinical investigation days on days 1 and 14. ETHICS AND DISSEMINATION: The trial has been approved by national ethical committees and will be conducted in accordance with the Declaration of Helsinki. Results will be published in international peer-reviewed open-access scientific journals. Research data from the trial will be deposited in an open-access online research data archive. TRIAL REGISTRATION NUMBER: NCT04633681.
AB - INTRODUCTION: Intake of free sugars in European countries is high and attempts to reduce sugar intake have been mostly ineffective. Non-nutritive sweeteners and sweetness enhancers (S&SEs) can maintain sweet taste in the absence of energy, but little is known about the impact of acute and repeated consumption of S&SE in foods on appetite. This study aims to evaluate the effect of acute and repeated consumption of two individual S&SEs and two S&SE blends in semisolid and solid foods on appetite and related behavioural, metabolic and health outcomes. METHODS AND ANALYSIS: A work package of the SWEET Project; this study consists of five double-blind randomised cross-over trials which will be carried out at five sites across four European countries, aiming to have n=213. Five food matrices will be tested across three formulations (sucrose-sweetened control vs two reformulated products with S&SE blends and no added sugar). Participants (body mass index 25-35 kg/m2; aged 18-60 years) will consume each formulation for 14 days. The primary endpoint is composite appetite score (hunger, inverse of fullness, desire to eat and prospective food consumption) over a 3-hour postprandial incremental area under the curve during clinical investigation days on days 1 and 14. ETHICS AND DISSEMINATION: The trial has been approved by national ethical committees and will be conducted in accordance with the Declaration of Helsinki. Results will be published in international peer-reviewed open-access scientific journals. Research data from the trial will be deposited in an open-access online research data archive. TRIAL REGISTRATION NUMBER: NCT04633681.
KW - General endocrinology
KW - NUTRITION & DIETETICS
KW - Protocols & guidelines
KW - PUBLIC HEALTH
U2 - 10.1136/bmjopen-2022-063903
DO - 10.1136/bmjopen-2022-063903
M3 - Article
C2 - 36564114
AN - SCOPUS:85144635488
SN - 2044-6055
VL - 12
JO - BMJ Open
JF - BMJ Open
IS - 12
M1 - e063903
ER -